- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT04936217
Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients (ELESDUCCBM)
Long-term Evaluation of the Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients
Continent Cutaneous Urinary Deviation (CUD), using the Mitrofanoff, Yang-Monti or Casale principle, is offered to patients with neurological diseases who are unable to perform intermittent catheterisation through the native urethra due to upper limb disability.
There is very little data in the literature examining the long-term efficacy and complications of this technique. The main objective of this study is to evaluate the effectiveness of long-term CUDs in spinal cord injury patients. The secondary objectives are to evaluate the surgical complications and the impact on the patient's quality of life.
For each patient, several data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly and any immediate or late complications. In a second stage, a questionnaire survey will be conducted by telephone.
연구 개요
상태
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Gard
-
Nîmes, Gard, 프랑스, 30029
- Nîmes University Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
Specific inclusion criteria for the study :
- no history of continuous cystostomy in another centre
- a follow-up > 24 months,
- a continent cutaneous urinary diversion for a spinal cord injury.
General inclusion criteria :
- Patient affiliated to or beneficiary of a health insurance scheme.
- Adult patient (≥18 years of age) and under 85 years of age.
Exclusion Criteria:
- Criteria for non-inclusion specific to the study :
- All urinary incontinence outside of medullary waiting period.
- A history of continuous cystostomy in another centre.
- A follow-up of less than 24 months,
- a continent cutaneous urinary diversion for a neurological pathology other than spinal cord injury.
General criteria for non-inclusion :
- Patient in a period of exclusion determined by another study.
- Patient for whom it is impossible to give enlightened information.
- Patient under legal protection, guardianship or curatorship.
- Patient unable to express consent
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 보병대
- 시간 관점: 회고전
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Patients operated for Continent Cutaneous Urinary Diversion, April 2004 - October 2017
The study focuses of a population of 70 patients operated between April 2004 and October 2017 au Nîmes University Hospital for Cutaneous Urinary Diversion.
|
For each patient, the following data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly, immediate and later complications.
A telephone survey will be conducted by means of a questionnaire in order to evaluate the patient's quality of life.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Efficacy of continent cutaneous urinary derivation: catheterisation.
기간: 3 -16 years after their operation
|
The minimum frequency of urinary catheterisation in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.
|
3 -16 years after their operation
|
|
Efficacy of continent cutaneous urinary derivation:leakage
기간: 3 -16 years after their operation
|
Absence of leakage through the cystostomy in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.
|
3 -16 years after their operation
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Surgical complications and impact on the patient's quality of life: Age at start of care
기간: 3 -16 years after their operation
|
The patient's age will be noted at the start of care
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: Sex
기간: 3 -16 years after their operation
|
The patient's sex will be noted at the start of care
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: Body Mass Index
기간: 3 -16 years after their operation
|
The patient's Body Mass Index will be noted at the start of care
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: ASA score
기간: 3 -16 years after their operation
|
The ASA Physical Status Classification System is used to assess and communicate a patient's pre-anesthesia medical comorbidities. The classification system alone does not predict the perioperative risks, but used with other factors (eg, type of surgery, frailty, level of deconditioning) it can be helpful in predicting perioperative risks. ASA I = A normal healthy patient ASA II = A patient with mild systemic disease ASA III = A patient with severe systemic disease ASA IV = A patient with severe systemic disease that is a constant threat to life ASA V = A moribund patient who is not expected to survive without the operation ASA VI = A declared brain-dead patient whose organs are being removed for donor purposes |
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: ASIA score
기간: 3 -16 years after their operation
|
The ASIA (American Spinal Injury Association) assessment is the gold standard for assessing and documenting sensory and motor impairments after Spinal Cord Injury. The score ranges from A to E as follows: A = Complete injury. No motor or sensory function is preserved in the sacral segments S4 or S5. B = Sensory incomplete. Sensory but not motor function is preserved below the level of injury, including the sacral segments. C = Motor incomplete. Motor function is preserved below the level of injury, and more than half of muscles tested below the level of injury have a muscle grade less than 3 (see muscle strength scores table). D = Motor incomplete. Motor function is preserved below the level of injury and at least half of the key muscles below the neurological level have a muscle grade of 3 or more. E = Normal. No motor or sensory deficits, but deficits existed in the past. This score will be used to evaluate the patient at the start of care. |
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: Bladder dysfunction
기간: 3 -16 years after their operation
|
The type of bladder dysfunction will be evaluated by urodynamic evaluation
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: urinary tract anomalies evaluated via a morphological examination.
기간: 3 -16 years after their operation
|
Urinary tract anomalies will be evaluated via a morphological examination (using ultrasound and / or tomodensitometry).
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: cytometry
기간: 3 -16 years after their operation
|
Urinary tract anomalies will be evaluated via cytometry
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: creatinine clearance
기간: 3 -16 years after their operation
|
Urinary tract anomalies will be evaluated according to the patient's creatinine clearance
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: operative indications
기간: 3 -16 years after their operation
|
The indications for the initial surgery will be recorded.
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: mictional mode
기간: 3 -16 years after their operation
|
The patient's initial mictional mode will be recorded.
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: surgical set-up
기간: 3 -16 years after their operation
|
The patient's surgical set-up will be recorded.
|
3 -16 years after their operation
|
|
Surgical complications and impact on the patient's quality of life: immediate or later complications
기간: 3 -16 years after their operation
|
All immediate or later complications will be recorded.
|
3 -16 years after their operation
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- Local 2019/SD-01
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .